{
    "2020-04-18": [
        [
            {
                "time": "",
                "original_text": "医药“卖水人”的中国生意：A股四大CRO企业晒成绩，行业黄金期药明康德净利逆势下滑 盈利能力下降",
                "features": {
                    "keywords": [
                        "医药",
                        "CRO",
                        "药明康德",
                        "净利下滑",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}